CG ONCOLOGY, INC.

Highlights CG Oncology, Inc.

Equities

CGON

US1569441009

Market Closed - Nasdaq Other stock markets 01:30:00 25/05/2024 am IST			5-day change	1st Jan Change
32.71 ^USD	+9.07%		+10.02%	0.00%

24/05	Sector Update: Health Care Stocks Softer in Friday Afternoon Trading	MT
24/05	CG Oncology Shares Jump After Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Softer in Friday Afternoon Trading	24/05	MT
CG Oncology Shares Jump After Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint	24/05	MT
CG Oncology, Inc. to Present Positive Final Results from Phase 2 Core-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC At Asco 2024 Annual Meeting	24/05	CI
CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
CG Oncology, Inc. Announces Data from the Phase 3 BOND-003 Study Evaluating the Efficacy and Safety of Cretostimogene Monotherapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette Guerin	03/05	CI
PACS Group to raise $450 mln in US IPO at over $3 bln valuation	11/04	RE
CG Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut	10/02	RE
Fractyl Health valued at $654.6 mln in tepid debut	02/02	RE
Fractyl Health prices US IPO below range to raise $110 mln	02/02	RE
Fractyl Health targets up to $762 mln valuation in US IPO	29/01	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer